As paeonol group showed marked molecular changes in genes related to proliferation, namely FGF1 and TGF-β1, regulation of Akt by paeonol treatment in BPH may lead to modulation in downstream related to proliferation rather than downstream pathways related to apoptosis. The gene discussed is FGF1; the disease is benign prostatic hyperplasia.